Patents by Inventor Eric FORAT

Eric FORAT has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11214426
    Abstract: Described herein are pharmaceutical packaging systems which prevent oxidative degradation of oxygen-sensitive drugs, such systems including a primary packaging container with an oxygen permeable component, a secondary packaging with very low permeability to oxygen and an oxygen absorber.
    Type: Grant
    Filed: September 17, 2020
    Date of Patent: January 4, 2022
    Assignee: FRESENIUS KABI DEUTSCHLAND GMBH
    Inventors: Thomas Devouassoux, Eric Forat, James Kenneth Proctor
  • Publication number: 20210130071
    Abstract: Described herein are pharmaceutical packaging systems which prevent oxidative degradation of oxygen-sensitive drugs, such systems including a primary packaging container with an oxygen permeable component, a secondary packaging with very low permeability to oxygen and an oxygen absorber.
    Type: Application
    Filed: September 17, 2020
    Publication date: May 6, 2021
    Applicant: Fresenius Kabi Deutschland GmbH
    Inventors: Thomas DEVOUASSOUX, Eric FORAT, James Kenneth PROCTOR
  • Patent number: 10781027
    Abstract: Described herein are pharmaceutical packaging systems which prevent oxidative degradation of oxygen-sensitive drugs, such systems including a primary packaging container with an oxygen permeable component, a secondary packaging with very low permeability to oxygen and an oxygen absorber.
    Type: Grant
    Filed: February 6, 2019
    Date of Patent: September 22, 2020
    Assignee: Fresenius Kabi Deutschland GmbH
    Inventors: Thomas Devouassoux, Eric Forat, James Kenneth Proctor
  • Publication number: 20190168943
    Abstract: Described herein are pharmaceutical packaging systems which prevent oxidative degradation of oxygen-sensitive drugs, such systems including a primary packaging container with an oxygen permeable component, a secondary packaging with very low permeability to oxygen and an oxygen absorber.
    Type: Application
    Filed: February 6, 2019
    Publication date: June 6, 2019
    Applicant: Fresenius Kabi Deutschland GmbH
    Inventors: Thomas DEVOUASSOUX, Eric FORAT, James Kenneth PROCTOR
  • Patent number: 10214338
    Abstract: Described herein are pharmaceutical packaging systems which prevent oxidative degradation of oxygen-sensitive drugs, such systems including a primary packaging container with an oxygen permeable component, a secondary packaging with very low permeability to oxygen and an oxygen absorber.
    Type: Grant
    Filed: December 12, 2016
    Date of Patent: February 26, 2019
    Assignee: Fresenius Kabi Deutschland GmbH
    Inventors: Thomas Devouassoux, Eric Forat, James Kenneth Proctor
  • Publication number: 20170088333
    Abstract: Described herein are pharmaceutical packaging systems which prevent oxidative degradation of oxygen-sensitive drugs, such systems including a primary packaging container with an oxygen permeable component, a secondary packaging with very low permeability to oxygen and an oxygen absorber.
    Type: Application
    Filed: December 12, 2016
    Publication date: March 30, 2017
    Applicant: Fresenius Kabi Deutschland GmbH
    Inventors: Thomas DEVOUASSOUX, Eric FORAT, James Kenneth PROCTOR
  • Patent number: 9545473
    Abstract: Described herein are pharmaceutical packaging systems which prevent oxidative degradation of oxygen-sensitive drugs, such systems including a primary packaging container with an oxygen permeable component, a secondary packaging with very low permeability to oxygen and an oxygen absorber.
    Type: Grant
    Filed: December 14, 2015
    Date of Patent: January 17, 2017
    Assignee: Fresenius Kabi Deutschland GmbH
    Inventors: Thomas Devouassoux, Eric Forat, James Kenneth Proctor
  • Publication number: 20160100889
    Abstract: Described herein are pharmaceutical packaging systems which prevent oxidative degradation of oxygen-sensitive drugs, such systems including a primary packaging container with an oxygen permeable component, a secondary packaging with very low permeability to oxygen and an oxygen absorber.
    Type: Application
    Filed: December 14, 2015
    Publication date: April 14, 2016
    Inventors: Thomas DEVOUASSOUX, Eric FORAT, James Kenneth PROCTOR
  • Patent number: 9248229
    Abstract: Described herein are pharmaceutical packaging systems which prevent oxidative degradation of morphine, hydromorphone, promethazine and other oxygen-sensitive drugs, such systems including a syringe with an oxygen permeable tip cap, a hermetically sealed oxygen barrier blister packaging with very low permeability to oxygen and comprises ethylene vinyl, and an oxygen absorber.
    Type: Grant
    Filed: March 12, 2014
    Date of Patent: February 2, 2016
    Assignee: Becton, Dickinson France S.A.S.
    Inventors: Thomas Devouassoux, Eric Forat, James Kenneth Proctor
  • Publication number: 20140262883
    Abstract: Described herein are pharmaceutical packaging systems which prevent oxidative degradation of oxygen-sensitive drugs, such systems including a primary packaging container with an oxygen permeable component, a secondary packaging with very low permeability to oxygen and an oxygen absorber.
    Type: Application
    Filed: March 12, 2014
    Publication date: September 18, 2014
    Applicant: Becton Dickinson France S.A.S.
    Inventors: Thomas DEVOUASSOUX, Eric FORAT, James Kenneth PROCTOR